Vivos Therapeutics, Inc.
NCM: VVOSLive Quote
About Vivos Therapeutics, Inc.
Healthcare
Medical Devices
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
📊 Fundamental Analysis
Vivos Therapeutics, Inc. demonstrates a profit margin of -98.8%, which is below the sector average, suggesting competitive pressure.
The company recently reported 75.7% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -335.5%, which indicates that capital utilization is currently under pressure.
At a current price of $1.21, VVOS currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $1.08 - $7.95).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$9.73M
Trailing P/E
--
Forward P/E
-0.97
Beta (5Y)
6.90
52W High
$7.95
52W Low
$1.08
Avg Volume
170K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App